Legal Representation
Attorney
Christina Brown
USPTO Deadlines
Next Deadline
102 days remaining
NOA E-Mailed - SOU Required
Due Date
April 22, 2026
Extension Available
Until October 22, 2026
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 23, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 22, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Aug 22, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Aug 22, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 10, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 9, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 9, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 9, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 22, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 27, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 27, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 7, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 22, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 22, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jul 22, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 22, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 22, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jul 17, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 17, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 17, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 11, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 25, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 18, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products and preparations for treating solid tumors and hematological cancers
Class 042
Research and development in the pharmaceutical, biotechnology, and digital medicine fields
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"ONCOLOGY"